ICU Medical (ICUI) Competitors

ICU Medical (NASDAQ:ICUI) and Integra LifeSciences (NASDAQ:IART) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Is ICUI or IART more profitable?

Integra LifeSciences has a net margin of 2.63% compared to ICU Medical's net margin of -2.63%. Integra LifeSciences' return on equity of 14.27% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	-2.63%	5.38%	2.58%
Integra LifeSciences	2.63%	14.27%	5.98%

Which has more risk & volatility, ICUI or IART?

ICU Medical has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

Does the media refer more to ICUI or IART?

In the previous week, ICU Medical had 3 more articles in the media than Integra LifeSciences. MarketBeat recorded 8 mentions for ICU Medical and 5 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.19 beat ICU Medical's score of 0.96 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	4 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable valuation and earnings, ICUI or IART?

Integra LifeSciences has lower revenue, but higher earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.26B	1.15	-$29.66M	-$2.45	-43.40
Integra LifeSciences	$1.54B	1.58	$67.74M	$0.50	61.80

Does the MarketBeat Community favor ICUI or IART?

Integra LifeSciences received 53 more outperform votes than ICU Medical when rated by MarketBeat users. However, 64.48% of users gave ICU Medical an outperform vote while only 57.82% of users gave Integra LifeSciences an outperform vote.

Company	Underperform	Outperform
ICU Medical	Outperform Votes 383 64.48%	Underperform Votes 211 35.52%
Integra LifeSciences	Outperform Votes 436 57.82%	Underperform Votes 318 42.18%

Do institutionals & insiders have more ownership in ICUI or IART?

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 6.7% of ICU Medical shares are held by insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Do analysts prefer ICUI or IART?

ICU Medical presently has a consensus price target of $123.00, suggesting a potential upside of 15.67%. Integra LifeSciences has a consensus price target of $35.00, suggesting a potential upside of 13.27%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.10

Summary

Integra LifeSciences beats ICU Medical on 11 of the 18 factors compared between the two stocks.